Results
257
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
257 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$144.24 | -1.4% | 33.1% | US$13.6b | US$198.28 | PE806.9x | E39.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$113.06 | -8.5% | 141.9% | US$2.8t | US$139.32 | PE65.2x | E23.3% | 0.04% | Semiconductors | ||
ARES | US$147.10 | -2.4% | 48.3% | US$46.0b | US$151.50 | PE68.3x | E29.0% | 2.5% | Diversified Financials | ||
NU | US$12.41 | -4.5% | 55.9% | US$59.4b | US$13.68 | PB8.7x | E27.4% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$142.00 | 0.6% | 35.5% | US$173.8b | US$134.11 | PE54.7x | E26.1% | 2.4% | Diversified Financials | ||
PDD | US$130.80 | -2.6% | 45.6% | US$181.7b | US$207.25 | PE16.5x | E21.6% | n/a | Retail | ||
CG | US$47.20 | 1.7% | 32.4% | US$17.0b | US$48.30 | PS7.7x | E23.6% | 3.0% | Diversified Financials | ||
SMCI | US$712.19 | -9.4% | 115.6% | US$41.7b | US$1,033.54 | PE39.8x | E39.0% | n/a | Tech | ||
SYM | US$38.80 | 0.4% | -38.9% | US$22.7b | US$52.25 | PS2.6x | E131.1% | n/a | Capital Goods | ||
OWL | US$19.74 | -0.5% | 60.2% | US$28.2b | US$20.69 | PE144.5x | E88.2% | 3.6% | Diversified Financials | ||
LEGN | US$56.61 | -3.9% | -25.0% | US$10.3b | US$82.63 | PS30.1x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
SPOT | US$321.88 | 8.9% | 115.4% | US$64.6b | US$384.54 | PE128.2x | E29.5% | n/a | Media | ||
ELF | US$182.82 | 7.8% | 56.6% | US$10.3b | US$223.62 | PE80.7x | E21.7% | n/a | Household | ||
VRT | US$77.12 | -12.2% | 196.5% | US$28.9b | US$102.80 | PE58x | E30.4% | 0.1% | Capital Goods | ||
RYAN | US$60.61 | 5.0% | 39.8% | US$15.8b | US$60.68 | PE113.4x | E49.2% | 0.7% | Insurance | ||
ALNY | US$234.84 | -0.3% | 20.2% | US$29.7b | US$259.31 | PS14.8x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
PTC | US$173.80 | -2.6% | 19.2% | US$20.8b | US$203.05 | PE72.3x | E22.8% | n/a | Software | ||
TER | US$126.46 | -18.1% | 12.0% | US$19.7b | US$145.63 | PE39.8x | E22.3% | 0.4% | Semiconductors | ||
ZS | US$181.36 | -3.7% | 13.1% | US$27.4b | US$230.08 | PS13.5x | E50.9% | n/a | Software | ||
NTNX | US$49.43 | 0.2% | 63.7% | US$12.2b | US$74.54 | PS5.8x | E82.7% | n/a | Software | ||
CHK | US$77.79 | -4.4% | -7.8% | US$10.2b | US$104.59 | PE9.7x | E35.5% | 3.1% | Energy | ||
MPWR | US$821.78 | -4.2% | 46.9% | US$40.0b | US$839.22 | PE97.5x | E20.7% | 0.6% | Semiconductors | ||
ARM | US$149.00 | -8.9% | n/a | US$155.0b | US$126.11 | PE506.6x | E32.1% | n/a | Semiconductors |